Severe Combined Immunodeficiency
- Name
- Severe Combined Immunodeficiency
- Accession Number
- DBCAT000163
- Description
Not Available
- Drugs
Drug Drug Description Pegademase A modified form of bovine adenosine deaminase used to treat adenosine deaminase deficiency, a condition which leads to the formation of adenosine metabolites which are cytotoxic to lymphocytes. - Drugs & Drug Targets
Drug Target Type Pegademase Adenosine target Pegademase Growth factor receptor-bound protein 2 target